Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113

Molecular Medicine Reports

Volumn 11, Issue 1, 2015, Pages 212-218

  Shao, Yuan ^a   Sha, Xiao Ying ^b   Bai, Yan Xia ^a   Quan, Fang ^a   Wu, Sheng Li ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

A disintegrin and metalloproteinase 10; Invasion; Migration; Proliferation; TCA8113

Indexed keywords

ADAM10 ENDOPEPTIDASE; EPIDERMAL GROWTH FACTOR RECEPTOR; SMALL INTERFERING RNA; UVOMORULIN; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; CADHERIN; MEMBRANE PROTEIN; SECRETASE;

ARTICLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA CELL LINE; TCA8113 CELL LINE; TONGUE CARCINOMA; UPREGULATION; WESTERN BLOTTING; CELL MOTION; DRUG SCREENING; GENETICS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR; TUMOR CELL LINE;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; MEMBRANE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; TONGUE NEOPLASMS; TUMOR STEM CELL ASSAY;

EID: 84916196937     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2717     Document Type: Article

References (27)

1. Myers JN, Elkins T, Roberts D and Byers RM: Squamous cell carcinoma of the tongue in young adults: Increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 122: 44-51, 2000.
2. Hernández-Guerrero JC, Jacinto-Alemán LF, Jiménez-Farfán MD, Macario-Hernández A, Hernández-Flores F and Alcántara-Vázquez A: Prevalence trends of oral squamous cell carcinoma. Mexico City's General Hospital experience. Med Oral Patol Oral Cir Bucal 18: e306-e311, 2013.
3. Bagan J, Sarrion G and Jimenez Y: Oral cancer: clinical features. Oral Oncol 46: 414-417, 2010.
4. Haddad RI and Shin DM: Recent advances in head and neck cancer. N Engl J Med 359: 1143-1154, 2008.
5. Duffy MJ, Mullooly M, O'Donovan N, Sukor S, Crown J, Pierce A and McGowan PM: The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? Clin Proteomics 8: 9, 2011.
6. Lin J, Luo J and Redies C: Differential expression of five members of the ADAM family in the developing chicken brain. Neuroscience 157: 360-375, 2008.
7. Murphy G: The ADAMs: signalling scissors in the tumour microenvironment. Nat Rev Cancer 8: 929-941, 2008.
8. Lu X, Lu D, Scully M and Kakkar V: ADAM proteins-therapeutic potential in cancer. Curr Cancer Drug Targets 8: 720-732, 2008.
9. Yuan S, Lei S and Wu S: ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells. Oncol Rep 30: 1715-1722, 2013.
10. Doberstein K, Pfeilschifter J and Gutwein P: The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma. Carcinogenesis 32: 1713-1723, 2011.
11. Gaida MM, Haag N, Günther F, et al: Expression of A disin-tegrin and metalloprotease 10 in pancreatic carcinoma. Int J Mol Med 26: 281-288, 2010.
12. Guo J, He L, Yuan P, et al: ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway. Oncol Rep 28: 1709-1718, 2012.
13. Wang YY, Ye ZY, Li L, Zhao ZS, Shao QS and Tao HQ: ADAM 10 is associated with gastric cancer progression and prognosis of patients. J Surg Oncol 103: 116-123, 2011.
14. Prox J, Willenbrock M, Weber S, et al: Tetraspanin15 regulates cellular trafficking and activity of the ectodomain sheddase ADAM10. Cell Mol Life Sci 69: 2919-2932, 2012.
15. Turner SL, Blair-Zajdel ME and Bunning RA: ADAMs and ADAMTSs in cancer. Br J Biomed Sci 66: 117-128, 2009.
16. Jones AV, Lambert DW, Speight PM and Whawell SA: ADAM 10 is over expressed in oral squamous cell carcinoma and contributes to invasive behaviour through a functional association with αvβ6 integrin. FEBS Lett 587: 3529-3534, 2013.
17. Shao Y, Zhang SQ, Quan F, Zhang PF and Wu SL: MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line. Oncol Lett 6: 1636-1640, 2013.
18. Lee SB, Schramme A, Doberstein K, et al: ADAM10 is upregulated in melanoma metastasis compared with primary melanoma. J Invest Dermatol 130: 763-773, 2010.
19. Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H and Zhang Z: Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer. Int J Cancer 120: 1909-1913, 2007.
20. Armanious H, Gelebart P, Anand M, Belch A and Lai R: Constitutive activation of metalloproteinase ADAM10 in mantle cell lymphoma promotes cell growth and activates the TNFα/NFκB pathway. Blood 117: 6237-6246, 2011.
21. Zheng X, Jiang F, Katakowski M, Lu Y and Chopp M: ADAM17 promotes glioma cell malignant phenotype. Mol Carcinog 51: 150-164, 2012.
22. Ebsen H, Schröder A, Kabelitz D and Janssen O: Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells. PLoS One 8: e76853, 2013.
23. Normanno N, De Luca A, Bianco C, et al: Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 366: 2-16, 2006.
24. Yan Y, Shirakabe K and Werb Z: The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 158: 221-226, 2002.
25. Millichip MI, Dallas DJ, Wu E, Dale S and McKie N: The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun 245: 594-598, 1998.
26. Pan Y, Han C, Wang C, et al: ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1. J Mol Endocrinol 49: 21-33, 2012.
27. Solanas G, Cortina C, Sevillano M and Batlle E: Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling. Nat Cell Biol 13: 1100-1107, 2011.